BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abd El-fattah EE, Zakaria AY. Metformin modulate immune fitness in hepatocellular carcinoma: Molecular and cellular approach. International Immunopharmacology 2022;109:108889. [DOI: 10.1016/j.intimp.2022.108889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Abd El-Fattah EE. Tumor lysis syndrome promotes cancer chemoresistance and relapse through AMPK inhibition. Int Immunopharmacol 2023;114:109568. [PMID: 36527883 DOI: 10.1016/j.intimp.2022.109568] [Reference Citation Analysis]
2 Nojima I, Wada J. Metformin and Its Immune-Mediated Effects in Various Diseases. Int J Mol Sci 2023;24. [PMID: 36614197 DOI: 10.3390/ijms24010755] [Reference Citation Analysis]
3 Oura K, Morishita A, Tani J, Masaki T. Antitumor Effects and Mechanisms of Metabolic Syndrome Medications on Hepatocellular Carcinoma. J Hepatocell Carcinoma 2022;9:1279-98. [PMID: 36545268 DOI: 10.2147/JHC.S392051] [Reference Citation Analysis]
4 Abd El-fattah EE, Selim HM. Reprograming immune microenvironment modulates CD47 cancer stem cells in hepatocellular carcinoma. International Immunopharmacology 2022;113:109475. [DOI: 10.1016/j.intimp.2022.109475] [Reference Citation Analysis]
5 Abd El-fattah EE, Zakaria AY. Targeting HSP47 and HSP70: promising therapeutic approaches in liver fibrosis management. J Transl Med 2022;20:544. [DOI: 10.1186/s12967-022-03759-z] [Reference Citation Analysis]
6 Luna-marco C, Ubink A, Kopsida M, Heindryckx F. Endoplasmic Reticulum Stress and Metabolism in Hepatocellular Carcinoma. The American Journal of Pathology 2022. [DOI: 10.1016/j.ajpath.2022.09.012] [Reference Citation Analysis]
7 Abd El-Fattah EE. IDO/kynurenine pathway in cancer: possible therapeutic approaches. J Transl Med 2022;20:347. [PMID: 35918736 DOI: 10.1186/s12967-022-03554-w] [Reference Citation Analysis]